These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31962185)
1. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling. Wang F; Mi K; Ahmad I; Xie S; Hussain HI; Yuan Z; Dai M; Huang L Microb Pathog; 2020 Apr; 141():103981. PubMed ID: 31962185 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine. Yan L; Xie S; Chen D; Pan Y; Tao Y; Qu W; Liu Z; Yuan Z; Huang L Sci Rep; 2017 Jun; 7(1):4064. PubMed ID: 28642571 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens. Nan J; Hao H; Xie S; Pan Y; Xi C; Mao F; Liu Z; Huang L; Yuan Z J Vet Pharmacol Ther; 2017 Dec; 40(6):641-655. PubMed ID: 28464333 [TBL] [Abstract][Full Text] [Related]
4. Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits. Zhou YF; Yu Y; Sun J; Tao MT; Zhou WJ; Li X; Liao XP; Liu YH Anaerobe; 2016 Jun; 39():150-7. PubMed ID: 27060276 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs. Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of isopropoxy benzene guanidine against Lu Y; Yang L; Zhang W; Li J; Peng X; Qin Z; Zeng Z; Zeng D Front Vet Sci; 2022; 9():1004248. PubMed ID: 36246309 [TBL] [Abstract][Full Text] [Related]
7. Zhang W; Lu Y; Ma M; Yang J; Huang H; Peng X; Zeng Z; Zeng D Front Vet Sci; 2024; 11():1362292. PubMed ID: 38756506 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers. Sang K; Hao H; Huang L; Wang X; Yuan Z Front Vet Sci; 2015; 2():80. PubMed ID: 26779495 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling. Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic modeling of cyadox against Escherichia coli in swine. Huang L; Maan MK; Xu D; Bakr Shabbir MA; Dai M; Yuan Z Microb Pathog; 2019 Oct; 135():103650. PubMed ID: 31376503 [No Abstract] [Full Text] [Related]
11. Dosage Regimen Formulation and Therapeutic Effect Evaluation of Cyadox Nanosuspension Against Dairy Cow Mastitis Caused by Staphylococcus aureus. Yue T; Xie S; Meng K; Liu S; Pan Y; Qu W; Liu Z; Chen D Curr Drug Deliv; 2021; 18(7):965-974. PubMed ID: 33302838 [TBL] [Abstract][Full Text] [Related]
12. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model. Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311 [TBL] [Abstract][Full Text] [Related]
13. Establishment of valnemulin susceptibility breakpoint against Clostridium perfringens in rabbits. Tao MT; Zhou YF; Sun J; Liu YH; Liao XP Anaerobe; 2017 Dec; 48():118-120. PubMed ID: 28801120 [TBL] [Abstract][Full Text] [Related]
14. Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers. Lee HK; DeVito V; Vercelli C; Tramuta C; Nebbia P; Re G; Kovalenko K; Giorgi M Res Vet Sci; 2017 Jun; 112():26-33. PubMed ID: 28113087 [TBL] [Abstract][Full Text] [Related]
15. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine. Sun D; Mi K; Hao H; Xie S; Chen D; Huang L BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661 [TBL] [Abstract][Full Text] [Related]
16. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264 [TBL] [Abstract][Full Text] [Related]
17. Impacts of Microbial based Therapy on Growth Performance, Intestinal Health, Carcass Traits and Economic Efficiency of Clostridium perfringens-Infected Cobb and Arbor Acres Broilers. Sallam EA; Mohammed LS; Elbasuni SS; Azam AE; Soliman MM Vet Med Sci; 2021 May; 7(3):773-791. PubMed ID: 33720539 [TBL] [Abstract][Full Text] [Related]
18. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs. Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843 [TBL] [Abstract][Full Text] [Related]
19. Incidence and Antimicrobial Susceptibility to Clostridium perfringens in Premarket Broilers in Taiwan. Fan YC; Wang CL; Wang C; Chen TC; Chou CH; Tsai HJ Avian Dis; 2016 Jun; 60(2):444-9. PubMed ID: 27309285 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals. Lee DH; Birhanu BT; Lee EB; Lee SJ; Boby N; Park YS; Park SC Vet Res; 2020 Oct; 51(1):131. PubMed ID: 33059768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]